Citations (177)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Katarzyna Gaweł, Krzysztof Dąbkowski, Iwona Zawada & Teresa Starzyńska. (2022) Progression risk factors of ulcerative proctitis. Scandinavian Journal of Gastroenterology 57:12, pages 1406-1411.
Read now
Read now
Isak Östlund, Mårten Werner & Pontus Karling. (2021) Self-monitoring with home based fecal calprotectin is associated with increased medical treatment. A randomized controlled trial on patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 56:1, pages 38-45.
Read now
Read now
Alessandro Vitello, Endrit Shahini, Fabio S. Macaluso, Gaetano C. Morreale, Emanuele Sinagra, Socrate Pallio & Marcello Maida. (2020) Endoscopic surveillance of colorectal cancer in inflammatory bowel diseases: a review of the literature. Expert Review of Anticancer Therapy 20:10, pages 851-863.
Read now
Read now
Jose María Huguet, Luis Ferrer-Barceló, Patrícia Suárez, Cecilia Albert, Lara Gonzalez, Genesis Castillo, Carlos Boix, Laura García, Juan Gallego & Javier Sempere. (2018) Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?. Scandinavian Journal of Gastroenterology 53:10-11, pages 1286-1290.
Read now
Read now
Robin J Dart, Mark A Samaan, Nick Powell & Peter M Irving. (2017) Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis. Clinical and Experimental Gastroenterology 10, pages 57-66.
Read now
Read now
Inger Camilla Solberg, Marte Lie Høivik, Milada Cvancarova & Bjørn Moum. (2015) Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study). Scandinavian Journal of Gastroenterology 50:12, pages 1456-1462.
Read now
Read now
Jakob B. Seidelin. (2015) Regulation of antiapoptotic and cytoprotective pathways in colonic epithelial cells in ulcerative colitis. Scandinavian Journal of Gastroenterology 50:sup1, pages 1-29.
Read now
Read now
Johan Burisch & Pia Munkholm. (2015) The epidemiology of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:8, pages 942-951.
Read now
Read now
Krisztina B Gecse & Peter L Lakatos. (2014) Ulcerative proctitis: an update on the pharmacotherapy and management. Expert Opinion on Pharmacotherapy 15:11, pages 1565-1573.
Read now
Read now
Bun Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2014) Proximal disease extension and related predicting factors in ulcerative proctitis. Scandinavian Journal of Gastroenterology 49:2, pages 177-183.
Read now
Read now
Inger Camilla Solberg, Idar Lygren, Jørgen Jahnsen, Erling Aadland, Ole Høie, Milada Cvancarova, Tomm Bernklev, Magne Henriksen, Jostein Sauar, Morten H. Vatn, Bjørn Moum & And the IBSEN Study Group. (2009) Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scandinavian Journal of Gastroenterology 44:4, pages 431-440.
Read now
Read now
Peter Laszlo Lakatos & Laszlo Lakatos. (2008) Ulcerative proctitis: a review of pharmacotherapy and management. Expert Opinion on Pharmacotherapy 9:5, pages 741-749.
Read now
Read now
Prashant Kedia & Russell D Cohen. (2007) Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis. Therapeutics and Clinical Risk Management 3:5, pages 919-927.
Read now
Read now
Å. Nilsson. (2006) Optimizing management of distal ulcerative colitis. Scandinavian Journal of Gastroenterology 41:5, pages 511-523.
Read now
Read now
Paul Rutgeerts, Karel Geboes. (2001) Understanding Inflammatory Bowel Disease&The Clinician's Perspective. The European Journal of Surgery 167:586, pages 66-72.
Read now
Read now
Articles from other publishers (162)
Marco Valvano, Annalisa Capannolo, Nicola Cesaro, Gianpiero Stefanelli, Stefano Fabiani, Sara Frassino, Sabrina Monaco, Marco Magistroni, Angelo Viscido & Giovanni Latella. (2023) Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease. Nutrients 15:17, pages 3824.
Crossref
Crossref
Johan Burisch. (2023) Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort. APMIS 131:S147, pages 1-46.
Crossref
Crossref
G. R. Bikbavova, V. A. Akhmedov, S. I. Mozgovoy, L. I. Telyatnikova & E. A. Shmurygina. (2022) Periappendicular changes in patients with ulcerative collitis: overview and clinical observation. Experimental and Clinical Gastroenterology:9, pages 298-302.
Crossref
Crossref
Nazire E. Albayrak & Alexandros D. Polydorides. (2022) Characteristics and Outcomes of Left-sided Ulcerative Colitis With a Cecal/Periappendiceal Patch of Inflammation. American Journal of Surgical Pathology 46:8, pages 1116-1125.
Crossref
Crossref
Wolfgang Kruis, Britta Siegmund, Konrad Lesniakowski, Vladimir Simanenkov, Ludmila Khimion, Marcin Sobon, Glebs Delmans, Svetlana V Maksyashina, Oleg A Sablin, Juris Pokrotnieks, Yuriy Mostovoy, Olena Datsenko, Sayar Abdulkhakov, Andriy Dorofeyev, Olena Levchenko, Olga Alexeeva, Pavel Andreev, Ivan P Kolesnik, Emese Mihaly, Orest Abrahamovych, Malgorzata Baluta, Nataliia Kharchenko, Neshta Viacheslav, Yury Uspenskiy, Michael Vieth, Ralf Mohrbacher, Ralph Mueller & Roland Greinwald. (2022) Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial. Journal of Crohn's and Colitis.
Crossref
Crossref
Noa Krugliak Cleveland, Joana Torres & David T. Rubin. (2022) What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?. Gastroenterology 162:5, pages 1396-1408.
Crossref
Crossref
Yansheng Hao, Clara Yzet, Russell B. McBride, Aryeh Stock, Elisa Tiratterra, Antonietta D’Errico, Andrea Belluzzi, Eleonora Scaioli, Paolo Gionchetti, Giulia Roda, Ryan Ungaro, Jean-Frederic Colombel, Noam Harpaz & Huaibin Mabel Ko. (2021) Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis. Digestive Diseases and Sciences 67:4, pages 1311-1319.
Crossref
Crossref
Viraj C. Kariyawasam, Fadi H. Mourad, Nikola Mitrev, Sudarshan Paramsothy, Christian P. Selinger, Peter H. Katelaris, Brian Jones, Charles McDonald, Gavin Barr, Grace Chapman, James Cowlishaw, Jane Andrews & Rupert W. Leong. (2021) Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis. European Journal of Gastroenterology & Hepatology 33:12, pages 1524-1532.
Crossref
Crossref
Mirabella Zhao, Lóránt Gönczi, Peter L Lakatos & Johan Burisch. (2021) The Burden of Inflammatory Bowel Disease in Europe in 2020. Journal of Crohn's and Colitis 15:9, pages 1573-1587.
Crossref
Crossref
Yi Jiang, Daniel S Rim, Brandon Rodgers & Sushil Ahlawat. (2020) Sarcoidosis is associated with lower risks of penetrating disease and colectomy in hospitalized patients with inflammatory bowel disease. JGH Open 4:6, pages 1199-1206.
Crossref
Crossref
Maryam Alkhatry, Ahmad Al-Rifai, Vito Annese, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul Nathwani, Mazen S Taha & Jimmy K Limdi. (2020) First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World Journal of Gastroenterology 26:43, pages 6710-6769.
Crossref
Crossref
Britt Christensen, Stephen B Hanauer, Peter R Gibson, Jerrold R Turner, John Hart & David T Rubin. (2020) Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. Journal of Crohn's and Colitis 14:10, pages 1345-1353.
Crossref
Crossref
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi & Francesco Costa. (2019) Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. Digestive Diseases and Sciences 65:8, pages 2397-2402.
Crossref
Crossref
Mariabeatrice Principi, Antonella Contaldo, Francesco Paolo Bianchi, Giuseppe Losurdo, Andrea Iannone, Enzo Ierardi, Silvio Tafuri & Alfredo Di Leo. (2020) Inter-Observer Agreement of a New Endoscopic Score for Ulcerative Colitis Activity: Preliminary Experience. Diagnostics 10:4, pages 213.
Crossref
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Crossref
Rachele Ciccocioppo, Sara Bozzini, Elena Betti, Venerina Imbesi, Catherine Klersy, Lucia Sukovska Lakyova, Lukas Sukovsky, Jozef Benacka, Peter Kruzliak, Gino Roberto Corazza, Antonio Di Sabatino & Colomba Falcone. (2019) Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case–control study. Clinical and Experimental Medicine 19:3, pages 367-375.
Crossref
Crossref
Carl Eriksson, Sara Rundquist, Yang Cao, Scott Montgomery & Jonas Halfvarson. (2019) Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study. Gut 68:4, pages 623-632.
Crossref
Crossref
Johan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, Luisa Barros, Fernando Magro, Natalia Pedersen, Jens Kjeldsen, Zsuzsanna Vegh, Peter L Lakatos, Carl Eriksson, Jonas Halfvarson, Mathurin Fumery, Corinne Gower-Rousseau, Marko Brinar, Silvija Čuković-Čavka, Inna Nikulina, Elena Belousova, Sally Myers, Shaji Sebastian, Gediminas Kiudelis, Limas Kupcinskas, Doron Schwartz, Selwyn Odes, Ioannis P Kaimakliotis, Daniela Valpiani, Renata D’Incà, Riina Salupere, Stefania Chetcuti Zammit, Pierre Ellul, Dana Duricova, Martin Bortlik, Adrian Goldis, Hendrika Adriana Linda Kievit, Alina Toca, Svetlana Turcan, Jóngerð Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Ravi Misra, Naila Arebi, Pia Oksanen, Pekka Collin, Luisa de Castro, Vicent Hernandez, Ebbe Langholz & Pia Munkholm. (2019) Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study. Journal of Crohn's and Colitis 13:2, pages 198-208.
Crossref
Crossref
Saransh Jain, Vineet Ahuja & Jimmy K Limdi. (2019) Optimal management of acute severe ulcerative colitis. Postgraduate Medical Journal 95:1119, pages 32-40.
Crossref
Crossref
Jimmy K. Limdi & Francis A. Farraye. 2019. Clinical Gastrointestinal Endoscopy. Clinical Gastrointestinal Endoscopy
435
445.e3
.
Hagit Tulchinsky. 2019. The Kock Pouch. The Kock Pouch
117
134
.
Ian Craig Lawrance. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
141
153
.
Alessia Butera, Massimo Sanchez, Annamaria Pronio, Antonello Amendola, Daniela De Nitto, Nazzareno Di Carlo, Roberto Lande, Loredana Frasca, Francesco Borrini, Roberta Pica & Monica Boirivant. (2018) CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis. Frontiers in Immunology 9.
Crossref
Crossref
Takashi Taida, Makoto Arai, Mai Fujie, Naoki Akizue, Kentaro Ishikawa, Yuki Ohta, Shinsaku Hamanaka, Hideaki Ishigami, Kenichiro Okimoto, Keiko Saito, Daisuke Maruoka, Tomoaki Matsumura, Tomoo Nakagawa, Tatsuro Katsuno & Naoya Kato. (2018) Real-time Endoscopy-Guided Measurement of Rectal Mucosal Admittance Is a Novel and Safe Method for Predicting Ulcerative Colitis Relapse. Inflammatory Bowel Diseases 24:11, pages 2360-2365.
Crossref
Crossref
Firas Rinawi, Amit Assa, Corina Hartman, Yael Mozer Glassberg, Vered Nachmias Friedler, Yoram Rosenbach, Ari Silbermintz, Noam Zevit & Raanan Shamir. (2018) Long-term Extent Change of Pediatric-Onset Ulcerative Colitis. Journal of Clinical Gastroenterology 52:4, pages 326-332.
Crossref
Crossref
Makoto Naganuma, Nobuo Aoyama, Tomohiro Tada, Kiyonori Kobayashi, Fumihito Hirai, Kenji Watanabe, Mamoru Watanabe & Toshifumi Hibi. (2017) Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study. Journal of Gastroenterology 53:4, pages 494-506.
Crossref
Crossref
Gyorgy Kovacs, Nora Sipeki, Boglarka Suga, Tamas Tornai, Kai Fechner, Gary L. Norman, Zakera Shums, Peter Antal-Szalmas & Maria Papp. (2018) Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients. PLOS ONE 13:3, pages e0194166.
Crossref
Crossref
A. Meyer & X. Treton. (2018) Colitis ulcerosa. EMC - Tratado de Medicina 22:1, pages 1-8.
Crossref
Crossref
C. Eriksson, Y. Cao, S. Rundquist, Y. Zhulina, I. Henriksson, S. Montgomery & J. Halfvarson. (2017) Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010. Alimentary Pharmacology & Therapeutics 46:8, pages 748-757.
Crossref
Crossref
Johan Burisch, Ryan Ungaro, Ida Vind, Michelle V Prosberg, Flemming Bendtsen, Jean-Frederic Colombel & Marianne K. Vester-Andersen. (2017) Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. Journal of Crohn's and Colitis 11:10, pages 1200-1204.
Crossref
Crossref
H. Yanai, S. Ben-Shachar, L. Mlynarsky, L. Godny, M. Leshno, H. Tulchinsky & I. Dotan. (2017) The outcome of ulcerative colitis patients undergoing pouch surgery is determined by pre-surgical factors. Alimentary Pharmacology & Therapeutics 46:5, pages 508-515.
Crossref
Crossref
Yao-Wen Cheng & Monika Fischer. (2017) The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly. Current Treatment Options in Gastroenterology 15:3, pages 349-362.
Crossref
Crossref
G. Roda, N. Narula, R. Pinotti, A. Skamnelos, K. H. Katsanos, R. Ungaro, J. Burisch, J. Torres & J.-F. Colombel. (2017) Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Alimentary Pharmacology & Therapeutics 45:12, pages 1481-1492.
Crossref
Crossref
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B. Gecse, Ailsa L. Hart, Pieter Hindryckx, Cord Langner, Jimmy K. Limdi, Gianluca Pellino, Edyta Zagórowicz, Tim Raine, Marcus Harbord & Florian Rieder. (2017) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. Journal of Crohn's and Colitis 11:6, pages 649-670.
Crossref
Crossref
Jian Zeng, Lin Lv & Zhe-Chuan Mei. (2017) Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 32:3, pages 558-566.
Crossref
Crossref
Heyson Chi-hey Chan & Siew Chien Ng. (2016) Emerging biologics in inflammatory bowel disease. Journal of Gastroenterology 52:2, pages 141-150.
Crossref
Crossref
Thomas A. Ullman & Rona Yaeger. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
669
683
.
Mary E. Sherlock & Eric I. Benchimol. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
181
191
.
Jacques Cosnes & Harry Sokol. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
653
660
.
Jimmy K. Limdi & Francis A. Farraye. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
639
652
.
Natalia Manetti, Siro Bagnoli, Francesca Rogai, Andrea G. Bonanomi, Giancarlo Vannozzi, Martina Giannotta & Vito Annese. (2016) Disease Course and Colectomy Rate of Ulcerative Colitis. Inflammatory Bowel Diseases 22:8, pages 1945-1953.
Crossref
Crossref
Makoto Naganuma, Nobuo Aoyama, Yasuo Suzuki, Haruo Nishino, Kiyonori Kobayashi, Fumihito Hirai, Kenji Watanabe & Toshifumi Hibi. (2016) Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis. Journal of Crohn's and Colitis 10:7, pages 828-836.
Crossref
Crossref
Cristiano Pagnini, Francesca Menasci, Federico Desideri, Vito D. Corleto, Gianfranco Delle Fave & Emilio Di Giulio. (2016) Endoscopic scores for inflammatory bowel disease in the era of ‘mucosal healing’: Old problem, new perspectives. Digestive and Liver Disease 48:7, pages 703-708.
Crossref
Crossref
Hwajeong Lee, Maria Westerhoff, Bo Shen & Xiuli Liu. (2016) Clinical Aspects of Idiopathic Inflammatory Bowel Disease: A Review for Pathologists. Archives of Pathology & Laboratory Medicine 140:5, pages 413-428.
Crossref
Crossref
H. Anzai, K. Hata, J. Kishikawa, H. Ishii, T. Nishikawa, T. Tanaka, J. Tanaka, T. Kiyomatsu, K. Kawai, H. Nozawa, S. Kazama, H. Yamaguchi, S. Ishihara, E. Sunami, J. Kitayama & T. Watanabe. (2016) Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. Colorectal Disease 18:3, pages O97-O102.
Crossref
Crossref
Leslie M Higuchi, Brian P Regan & Athos Bousvaros. 2016. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition
341
368
.
Jaime L. Bohl & Kathryn Sobba. (2015) Indications and Options for Surgery in Ulcerative Colitis. Surgical Clinics of North America 95:6, pages 1211-1232.
Crossref
Crossref
Stephen B. Hanauer & Daniel K. Podolsky. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1378
1417
.
Kouichi Asano, Motohiro Esaki, Junji Umeno, Atsushi Hirano, Yuji Maehata, Tomohiko Moriyama, Shotaro Nakamura, Takayuki Matsumoto & Takanari Kitazono. (2015) Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis. Journal of Gastroenterology 50:11, pages 1094-1102.
Crossref
Crossref
David Farmer. (2015) QIPP and ulcerative colitis: Optimising the management of patients in primary care. British Journal of Healthcare Management 21:10, pages 465-468.
Crossref
Crossref
E. Safroneeva, S. Vavricka, N. Fournier, F. Seibold, C. Mottet, A. Nydegger, J. Ezri, A. Straumann, G. Rogler & A. M. Schoepfer. (2015) Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Alimentary Pharmacology & Therapeutics 42:5, pages 540-548.
Crossref
Crossref
Brian Bressler, John K. Marshall, Charles N. Bernstein, Alain Bitton, Jennifer Jones, Grigorios I. Leontiadis, Remo Panaccione, A. Hillary Steinhart, Francis Tse, Brian Feagan, Waqqas Afif, Edmond-Jean Bernard, Mark Borgaonkar, Shane Devlin, Richard Fedorak, Geoffrey C. Nguyen, Robert Penner, Laurent Peyrin-Biroulet, Walter Reinisch, Cynthia H. Seow, Richmond Sy, Laura Targownik, Peter Thomson, Gert Van Assche & Chadwick Williams. (2015) Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus. Gastroenterology 148:5, pages 1035-1058.e3.
Crossref
Crossref
Amandeep K. Shergill, Jenifer R. Lightdale, David H. Bruining, Ruben D. Acosta, Vinay Chandrasekhara, Krishnavel V. Chathadi, G. Anton Decker, Dayna S. Early, John A. Evans, Robert D. Fanelli, Deborah A. Fisher, Lisa Fonkalsrud, Kimberly Foley, Joo Ha Hwang, Terry L. Jue, Mouen A. Khashab, V. Raman Muthusamy, Shabana F. Pasha, John R. Saltzman, Ravi Sharaf, Brooks D. Cash & John M. DeWitt. (2015) The role of endoscopy in inflammatory bowel disease. Gastrointestinal Endoscopy 81:5, pages 1101-1121.e13.
Crossref
Crossref
Xian-rui Wu, Xiu-li Liu, Seymour Katz & Bo Shen. (2015) Pathogenesis, Diagnosis, and Management of Ulcerative Proctitis, Chronic Radiation Proctopathy, and Diversion Proctitis. Inflammatory Bowel Diseases 21:3, pages 703-715.
Crossref
Crossref
Jakob Benedict Seidelin, Mehmet Coskun, Peter Helding Kvist, Thomas Lindebo Holm, Kristine Holgersen & Ole Haagen Nielsen. (2014) IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis. Journal of Gastroenterology 50:2, pages 180-190.
Crossref
Crossref
Ivan J. Fuss & Warren Strober. 2015. Mucosal Immunology. Mucosal Immunology
1573
1612
.
Natalia Pedersen, Peter Thielsen, Lars Martinsen, Mette Bennedsen, Anne Haaber, Ebbe Langholz, Zsuzsanna Végh, Dana Duricova, Tine Jess, Sally Bell, Johan Burisch & Pia Munkholm. (2014) eHealth. Inflammatory Bowel Diseases 20:12, pages 2276-2285.
Crossref
Crossref
Mitchell R. K. L. Lie, Shannon L. Kanis, Bettina E. Hansen & C. Janneke van der Woude. (2014) Drug Therapies for Ulcerative Proctitis. Inflammatory Bowel Diseases 20:11, pages 2157-2178.
Crossref
Crossref
Philip J. Smith, Adam P. Levine, Jenny Dunne, Paul Guilhamon, Mark Turmaine, Gavin W. Sewell, Nuala R. OʼShea, Roser Vega, Jennifer C. Paterson, Dahmane Oukrif, Stephan Beck, Stuart L. Bloom, Marco Novelli, Manuel Rodriguez-Justo, Andrew M. Smith & Anthony W. Segal. (2014) Mucosal Transcriptomics Implicates Under Expression of BRINP3 in the Pathogenesis of Ulcerative Colitis. Inflammatory Bowel Diseases 20:10, pages 1802-1812.
Crossref
Crossref
Marianne K Vester-Andersen, Michelle V Prosberg, Tine Jess, Mikael Andersson, Bo G Bengtsson, Thomas Blixt, Pia Munkholm, Flemming Bendtsen & Ida Vind. (2014) Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy. American Journal of Gastroenterology 109:5, pages 705-714.
Crossref
Crossref
Gionata Fiorino, Daniela Gilardi, Patrizia Naccarato, Orsola R. Sociale & Silvio Danese. (2014) Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis. Digestive and Liver Disease 46:4, pages 330-334.
Crossref
Crossref
S. Schreiber & O. Bachmann. (2014) Neue Biologika für die Behandlung chronisch-entzündlicher DarmerkrankungenNew biologics for treatment of chronic inflammatory bowel diseases. Der Internist 55:4, pages 367-376.
Crossref
Crossref
Cloé Charpentier, Julia Salleron, Guillaume Savoye, Mathurin Fumery, Véronique Merle, Jean-Eric Laberenne, Francis Vasseur, Jean-Louis Dupas, Antoine Cortot, Luc Dauchet, Laurent Peyrin-Biroulet, Eric Lerebours, Jean-Frédéric Colombel & Corinne Gower-Rousseau. (2014) Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 63:3, pages 423-432.
Crossref
Crossref
J. P. Gisbert & M. Chaparro. (2014) Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Alimentary Pharmacology & Therapeutics 39:5, pages 459-477.
Crossref
Crossref
Johan Burisch, Natalia Pedersen, Silvja Cukovic-Cavka, Niksa Turk, Ioannis Kaimakliotis, Dana Duricova, Olga Shonová, Ida Vind, Søren Avnstrøm, Niels Thorsgaard, Susanne Krabbe, Vibeke Andersen, Frederik Dahlerup Jens, Jens Kjeldsen, Riina Salupere, Jónger Olsen, Kári Rubek Nielsen, Pia Manninen, Pekka Collin, Konstantinnos H. Katsanos, Epameinondas V. Tsianos, Karin Ladefoged, Laszlo Lakatos, Yvonne Bailey, Colm O’Morain, Doron Schwartz, Selwyn Odes, Matteo Martinato, Silvia Lombardini, Laimas Jonaitis, Limas Kupcinskas, Svetlana Turcan, Louisa Barros, Fernando Magro, Daniela Lazar, Adrian Goldis, Inna Nikulina, Elena Belousova, Alberto Fernandez, Vicent Hernandez, Sven Almer, Yaroslava Zhulina, Jonas Halfvarson, Her-Hsin Tsai, Shaji Sebastian, Peter Laszlo Lakatos, Ebbe Langholz & Pia Munkholm. (2014) Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe. Inflammatory Bowel Diseases 20:1, pages 36-46.
Crossref
Crossref
Sunil Samuel & Edward V. LoftusJr.Jr.. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
23
30
.
Carmen Cuffari. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
145
151
.
Alexandra D. Frolkis, Jonathan Dykeman, María E. Negrón, Jennifer deBruyn, Nathalie Jette, Kirsten M. Fiest, Talia Frolkis, Herman W. Barkema, Kevin P. Rioux, Remo Panaccione, Subrata Ghosh, Samuel Wiebe & Gilaad G. Kaplan. (2013) Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies. Gastroenterology 145:5, pages 996-1006.
Crossref
Crossref
M. Watanabe, H. Nishino, Y. Sameshima, A. Ota, S. Nakamura & T. Hibi. (2013) Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation - a placebo-controlled study. Alimentary Pharmacology & Therapeutics 38:3, pages 264-273.
Crossref
Crossref
Ashwin N. Ananthakrishnan & Ramnik J. Xavier. (2013) How Does Genotype Influence Disease Phenotype in Inflammatory Bowel Disease?. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
Thomas A. Ullman. 2013. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
531
545
.
S. K. Murthy, A. H. Steinhart, J. Tinmouth, P. C. Austin, N. Daneman & G. C. Nguyen. (2012)
Impact of
Clostridium difficile
colitis on 5-year health outcomes in patients with ulcerative colitis
. Alimentary Pharmacology & Therapeutics 36:11-12, pages 1032-1039.
Crossref
Crossref
Ingrid Ordás, Lars Eckmann, Mark Talamini, Daniel C Baumgart & William J Sandborn. (2012) Ulcerative colitis. The Lancet 380:9853, pages 1606-1619.
Crossref
Crossref
Joana Torres, Vincent Billioud, David B. Sachar, Laurent Peyrin-Biroulet & Jean-Frédéric Colombel. (2012) Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence. Inflammatory Bowel Diseases 18:7, pages 1356-1363.
Crossref
Crossref
Wojciech Blonski, Anna M. Buchner & Gary R. Lichtenstein. (2012) Clinical Predictors of Aggressive/Disabling Disease: Ulcerative Colitis and Crohn Disease. Gastroenterology Clinics of North America 41:2, pages 443-462.
Crossref
Crossref
F. Bermejo, I. Guerra & A. López-Sanromán. (2012) Colitis ulcerosa. Medicine - Programa de Formación Médica Continuada Acreditado 11:5, pages 266-274.
Crossref
Crossref
Fernando Magro, Andreia Rodrigues, Ana Isabel Vieira, Francisco Portela, Isabelle Cremers, José Cotter, Luis Correia, Maria Antónia Duarte, Maria Lourdes Tavares, Paula Lago, Paula Ministro, Paula Peixe, Susana Lopes & Elizabeth Benito Garcia. (2012) Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflammatory Bowel Diseases 18:3, pages 573-583.
Crossref
Crossref
Kristin Kaasen Jrgensen, Krzysztof Grzyb, Knut E.A. Lundin, Ole Petter F. Clausen, Geir Aamodt, Erik Schrumpf, Morten H. Vatn & Kirsten Muri Boberg. (2012) Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients. Inflammatory Bowel Diseases 18:3, pages 536-545.
Crossref
Crossref
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude. (2012) Trial discontinuation: lessons for future trial design?. Clinical Investigation 2:2, pages 147-152.
Crossref
Crossref
Sung-Ae Jung. (2012) Differential Diagnosis of Inflammatory Bowel Disease: What Is the Role of Colonoscopy?. Clinical Endoscopy 45:3, pages 254.
Crossref
Crossref
M Boirivant & A Cossu. (2011) Inflammatory bowel disease. Oral Diseases 18:1, pages 1-15.
Crossref
Crossref
Jacques Cosnes, Harry Sokol & Philippe Seksik. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
713
725
.
Charles N. Bernstein. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
343
363
.
Sunny Singh, Andrea Blanchard, John R. Walker, Lesley A. Graff, Norine Miller & Charles N. Bernstein. (2011) Common Symptoms and Stressors Among Individuals With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 9:9, pages 769-775.
Crossref
Crossref
James Buchanan, Sarah Wordsworth, Tariq Ahmad, Angela Perrin, Severine Vermeire, Miquel Sans, Jenny Taylor & Derek Jewell. (2011) Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers. Journal of Crohn's and Colitis 5:4, pages 301-316.
Crossref
Crossref
C. Bello, J. Belaiche, E. Louis & C. Reenaers. (2011) Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids. Journal of Crohn's and Colitis 5:3, pages 196-202.
Crossref
Crossref
M. S. Harris & G. R. Lichtenstein. (2011) Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis. Alimentary Pharmacology & Therapeutics 33:9, pages 996-1009.
Crossref
Crossref
Jacques Cosnes, Corinne Gower–Rousseau, Philippe Seksik & Antoine Cortot. (2011) Epidemiology and Natural History of Inflammatory Bowel Diseases. Gastroenterology 140:6, pages 1785-1794.e4.
Crossref
Crossref
Dana Duricova, Natalia Pedersen, Martin Lenicek, Christian Jakobsen, Milan Lukas, Vibeke Wewer & Pia Munkholm. (2011) The clinical implication of drug dependency in children and adults with inflammatory bowel disease: A review. Journal of Crohn's and Colitis 5:2, pages 81-90.
Crossref
Crossref
Edouard Louis, Catherine Van Kemseke & Catherine Reenaers. (2011) Necessity of phenotypic classification of Inflammatory Bowel Disease. Best Practice & Research Clinical Gastroenterology 25, pages S2-S7.
Crossref
Crossref
David T. Rubin & Jami A. Rothe. (2010) The Peri-appendiceal Red Patch in Ulcerative Colitis: Review of the University of Chicago Experience. Digestive Diseases and Sciences 55:12, pages 3495-3501.
Crossref
Crossref
G. B. Melton, R. P. Kiran, V. W. Fazio, J. He, B. Shen, J. R. Goldblum, J.‐P. Achkar, Ian C. Lavery & Feza H. Remzi. (2009) Do preoperative factors predict subsequent diagnosis of Crohn’s disease after ileal pouch‐anal anastomosis for ulcerative or indeterminate colitis?. Colorectal Disease 12:10, pages 1026-1032.
Crossref
Crossref
Derek P Jewell, Lloyd R Sutherland, John WD McDonald & Brian G Feagan. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
232
247
.
Uma Sharma, Rajiv R. Singh, Vineet Ahuja, Govind K. Makharia & Naranamangalam R. Jagannathan. (2010) Similarity in the metabolic profile in macroscopically involved and un-involved colonic mucosa in patients with inflammatory bowel disease: an in vitro proton (1H) MR spectroscopy study. Magnetic Resonance Imaging 28:7, pages 1022-1029.
Crossref
Crossref
Manuel Barreiro-de Acosta, Fernando Magro, Daniel Carpio, Paula Lago, Ana Echarri, José Cotter, Santos Pereira, Raquel Gonçalves, Aurelio Lorenzo, Laura Carvalho, Javier Castro, Luisa Barros, Jorge Amil Dias, Susana Rodrigues, Francisco Portela, Camila Dias & Altamiro da Costa-Pereira. (2010) Ulcerative colitis in northern Portugal and Galicia in Spain. Inflammatory Bowel Diseases 16:7, pages 1227-1238.
Crossref
Crossref
Linda Vong, Jose G. P. Ferraz, Remo Panaccione, Paul L. Beck & John L. Wallace. (2010)
A pro-resolution mediator, prostaglandin D
2
, is specifically up-regulated in individuals in long-term remission from ulcerative colitis
. Proceedings of the National Academy of Sciences 107:26, pages 12023-12027.
Crossref
Crossref
Alissa J. Walsh & Graham L. Radford‐Smith. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
212
227
.
R. D. COHEN, A. P. YU, E. Q. WU, J. XIE, P. M. MULANI & J. CHAO. (2010) Systematic review: the costs of ulcerative colitis in Western countries. Alimentary Pharmacology & Therapeutics 31:7, pages 693-707.
Crossref
Crossref
Ebbe Langholz. (2010) Review: Current trends in inflammatory bowel disease: the natural history. Therapeutic Advances in Gastroenterology 3:2, pages 77-86.
Crossref
Crossref
Geert R. D'Haens. (2010) Top-down therapy for IBD: rationale and requisite evidence. Nature Reviews Gastroenterology & Hepatology 7:2, pages 86-92.
Crossref
Crossref
Shane M. Devlin & Remo Panaccione. (2010) Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up. Medical Clinics of North America 94:1, pages 1-18.
Crossref
Crossref
Teija Väistö, Eeva T. Aronen, Petteri Simola, Merja Ashorn & Kaija-Leena Kolho. (2010) Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflammatory Bowel Diseases 16:1, pages 27-35.
Crossref
Crossref
Shane M. Devlin & Remo Panaccione. (2009) Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up. Gastroenterology Clinics of North America 38:4, pages 577-594.
Crossref
Crossref
Andrea Cassinotti, Giovanni C Actis, Piergiorgio Duca, Alessandro Massari, Elisabetta Colombo, Elisa Gai, Vito Annese, Giuseppe D'Albasio, Gianpiero Manes, Simon Travis, Gabriele Bianchi Porro & Sandro Ardizzone. (2009) Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal. The American Journal of Gastroenterology 104:11, pages 2760-2767.
Crossref
Crossref
María Josefina Etchevers, Montserrat Aceituno, Orlando García-Bosch, Ingrid Ordás, Miquel Sans, Elena Ricart & Julián Panés. (2009) Risk factors and characteristics of extent progression in ulcerative colitis. Inflammatory Bowel Diseases 15:9, pages 1320-1325.
Crossref
Crossref
San Choon Kong. (2009) Probiotics and prebiotics in the management of ulcerative colitis. Food Science & Technology Bulletin: Functional Foods 5:8, pages 93-102.
Crossref
Crossref
Dorothy K.L. Chow, Rupert W.L. Leong, Kelvin K.F. Tsoi, Simon S.M. Ng, Wai-keung Leung, Justin C.Y. Wu, Vincent W.S. Wong, Francis K.L. Chan & Joseph J.Y. Sung. (2009) Long-term Follow-up of Ulcerative Colitis in the Chinese Population. American Journal of Gastroenterology 104:3, pages 647-654.
Crossref
Crossref
Dorothy K L Chow, Rupert W L Leong, Kelvin K F Tsoi, Simon S M Ng, Wai-keung Leung, Justin C Y Wu, Vincent W S Wong, Francis K L Chan & Joseph J Y Sung. (2009) Long-term Follow-up of Ulcerative Colitis in the Chinese Population. The American Journal of Gastroenterology 104:3, pages 647-654.
Crossref
Crossref
Zunwu Zhang & Hugh Kennedy. (2009) Ulcerative colitis: current medical therapy and strategies for improving medication adherence. European Journal of Gastroenterology & Hepatology 21:1, pages 1-8.
Crossref
Crossref
Jakob B. Seidelin & Ole H. Nielsen. (2008) Attenuated apoptosis response to Fas-ligand in active ulcerative colitis. Inflammatory Bowel Diseases 14:12, pages 1623-1629.
Crossref
Crossref
Mark H. Flasar, Sandra Quezada, Priti Bijpuria & Raymond K. Cross. (2008) Racial Differences in Disease Extent and Severity in Patients with Ulcerative Colitis: A Retrospective Cohort Study. Digestive Diseases and Sciences 53:10, pages 2754-2760.
Crossref
Crossref
Daniel C Baumgart, John K MacDonald & Brian Feagan. (2008) Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
M. Cottone, D. Scimeca, F. Mocciaro, G. Civitavecchia, G. Perricone & A. Orlando. (2008) Clinical course of ulcerative colitis. Digestive and Liver Disease 40, pages S247-S252.
Crossref
Crossref
Selwyn Odes. (2008) How expensive is inflammatory bowel disease? A critical analysis. World Journal of Gastroenterology 14:43, pages 6641.
Crossref
Crossref
JK. Triantafillidis, P. Cheracakis, E. Merikas, G. Malgarinos, F. Georgopoulos, I. Fouskas, M. Mylonaki & E. Giannakoulopoulou. 2008. IBD 2007 — Achievements in Research and Clinical Practice. IBD 2007 — Achievements in Research and Clinical Practice
13
29
.
Thomas A. Ullman. 2008. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
611
630
.
Jonas Halfvarson, Tine Jess, Lennart Bodin, Gunnar Järnerot, Pia Munkholm, Vibeke Binder & Curt Tysk. (2007) Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflammatory Bowel Diseases 13:12, pages 1536-1544.
Crossref
Crossref
Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Morten H. Vatn & Bjørn Moum. (2007) Are There Any Differences in Phenotype or Disease Course Between Familial and Sporadic Cases of Inflammatory Bowel Disease? Results of a Population-Based Follow-Up Study. The American Journal of Gastroenterology 102:9, pages 1955-1963.
Crossref
Crossref
N. Eleftheriadis, G. Lambrecht, G. D’Haens, F. Baert, M. Cabooter, E. Louis, G. Van Assche, P. Schurmans, P. Caenepeel, M. Van Outryve, P. Lammens, A. Van Gossum & M. De Vos. (2007) Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis. Journal of Crohn's and Colitis 1:1, pages 21-27.
Crossref
Crossref
Michele R Etling, Sarah Davies, Melanie Campbell, Raymond W Redline, Pingfu Fu & Alan D Levine. (2007) Maturation of the mucosal immune system underlies colitis susceptibility in interleukin-10-deficient (IL-10−/−) mice. Journal of Leukocyte Biology 82:2, pages 311-319.
Crossref
Crossref
Gil Y. Melmed, Robert Elashoff, Gary C. Chen, Igor Nastaskin, Konstantinos A. Papadakis, Eric A. Vasiliauskas, Weiqing Liu, Carol Landers, Andrew F. Ippoliti & Stephan R. Targan. (2007) Predicting a Change in Diagnosis From Ulcerative Colitis to Crohn’s Disease: A Nested, Case-Control Study. Clinical Gastroenterology and Hepatology 5:5, pages 602-608.
Crossref
Crossref
Daniel C Baumgart & William J Sandborn. (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. The Lancet 369:9573, pages 1641-1657.
Crossref
Crossref
Marian C Aldhous, Hazel E Drummond, Niall Anderson, M Reza Baneshi, Linda A Smith, Ian DR Arnott & Jack Satsangi. (2007) Smoking Habit and Load Influence Age at Diagnosis and Disease Extent in Ulcerative Colitis. The American Journal of Gastroenterology 102:3, pages 589-597.
Crossref
Crossref
Sang Hyoung Park, Young Min Kim, Suk-Kyun Yang, Sai-Hui Kim, Jeong-Sik Byeon, Seung-Jae Myung, Yun Kyung Cho, Chang-Sik Yu, Kwi-Sook Choi, Jun-Won Chung, Benjamin Kim, Kee Don Choi & Jin-Ho Kim. (2007) Clinical features and natural history of ulcerative colitis in Korea. Inflammatory Bowel Diseases 13:3, pages 278-283.
Crossref
Crossref
Constantinos Chatzicostas, Maria Roussomoustakaki, Spiros Potamianos, Gregorios Paspatis, Ioannis Mouzas, John Romanos, Helen Mavrogeni & Elias Kouroumalis. (2006) Factors associated with disease evolution in Greek patients with inflammatory bowel disease. BMC Gastroenterology 6:1.
Crossref
Crossref
P. GIONCHETTI, F. RIZZELLO, C. MORSELLI, R. TAMBASCO & M. CAMPIERI. (2006) Review article: aminosalicylates for distal colitis. Alimentary Pharmacology & Therapeutics 24:s3, pages 41-44.
Crossref
Crossref
Gary R. Lichtenstein, Russell Cohen, Beverly Yamashita & Robert H. Diamond. (2006) Quality of Life After Proctocolectomy With Ileoanal Anastomosis for Patients With Ulcerative Colitis. Journal of Clinical Gastroenterology 40:8, pages 669-677.
Crossref
Crossref
Magne Henriksen, Jrgen Jahnsen, Idar Lygren, Jostein Sauar, ystein Kjellevold, Tom Schulz, Morten H. Vatn & Bjrn Moum. (2006) Ulcerative colitis and clinical course: Results of a 5-year population-based follow-up study (the IBSEN study). Inflammatory Bowel Diseases 12:7, pages 543-550.
Crossref
Crossref
Ryan S. Carvalho, Vivian Abadom, Harrison P. Dilworth, Richard Thompson, Maria Oliva-Hemker & Carmen Cuffari. (2006) Indeterminate colitis: A significant subgroup of pediatric IBD. Inflammatory Bowel Diseases 12:4, pages 258-262.
Crossref
Crossref
Jonathan A. Leighton, Bo Shen, Todd H. Baron, Douglas G. Adler, Raquel Davila, James V. Egan, Douglas O. Faigel, Seng-Ian Gan, William K. Hirota, David Lichtenstein, Waqar A. Qureshi, Elizabeth Rajan, Marc J. Zuckerman, Trina VanGuilder & Robert D. Fanelli. (2006) ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointestinal Endoscopy 63:4, pages 558-565.
Crossref
Crossref
Robert Hilsden & Lloyd Sutherland. 2006. Challenges in Inflammatory Bowel Disease. Challenges in Inflammatory Bowel Disease
369
376
.
Subra Kugathasan, Marla C Dubinsky, David Keljo, M Susan Moyer, Paul A Rufo, Robert Wyllie, Mary Zachos & Jeffrey Hyams. (2005) Severe Colitis in Children. Journal of Pediatric Gastroenterology and Nutrition 41:4, pages 375-385.
Crossref
Crossref
Carmen Cuffari, Daniel H Present, Theodore M Bayless & Gary R Lichtenstein. (2005) Optimizing Therapy in Patients with Pancolitis. Inflammatory Bowel Diseases 11:10, pages 937-946.
Crossref
Crossref
Cosimo Prantera, Angelo Viscido, Livia Biancone, Antonio Francavilla, Lucio Giglio & Massimo Campieri. (2005) A New Oral Delivery System for 5-ASA: Preliminary Clinical Findings for MMX. Inflammatory Bowel Diseases 11:5, pages 421-427.
Crossref
Crossref
David S. Fefferman & Richard J. Farrell. (2005) Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice. Clinical Gastroenterology and Hepatology 3:1, pages 11-24.
Crossref
Crossref
Remo Panaccione & Lloyd R. Sutherland. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
269
290
.
Derek P Jewell & Lloyd R Sutherland. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
197
210
.
Roberta Pica, Omero Alessandro Paoluzi, Federico Iacopini, Adriana Marcheggiano, Pietro Crispino, Margherita Rivera, Antonino Bella, Adriana Consolazio & Paolo Paoluzi. (2004) Oral Mesalazine (5-ASA) Treatment May Protect Against Proximal Extension of Mucosal Inflammation in Ulcerative Proctitis. Inflammatory Bowel Diseases 10:6, pages 731-736.
Crossref
Crossref
P. Gionchetti, F. Rizzello, C. Morselli & M. Campieri. (2004) Problematic proctitis and distal colitis. Alimentary Pharmacology & Therapeutics 20, pages 93-96.
Crossref
Crossref
Philippe Marteau, Laurent Beaugerie, Yoram Bouhnik, Bernard Flourié, Luc Gambiez, Jean-Marie Reimund & Philippe Seksik. (2004) Introduction de l’argumentaire. Gastroentérologie Clinique et Biologique 28:10, pages 961-963.
Crossref
Crossref
Luis Menchén, Arturo L Colón, Jos LM Madrigal, Luis Beltrán, Sofa Botella, Ignacio Lizasoain, Juan C Leza, Mara A Moro, Pedro Menchén, Enrique Cos & Pedro Lorenzo. (2004) Activity of Inducible and Neuronal Nitric Oxide Synthases in Colonic Mucosa Predicts Progression of Ulcerative Colitis. American Journal of Gastroenterology 99:9, pages 1756-1764.
Crossref
Crossref
Craig A Solem & Edward V LoftusJr.Jr.. (2004) Management of refractory inflammatory bowel disease. Gastroenterology Clinics of North America 33:2, pages 319-334.
Crossref
Crossref
Vibeke Binder. (2004) Epidemiology of IBD during the twentieth century: an integrated view. Best Practice & Research Clinical Gastroenterology 18:3, pages 463-479.
Crossref
Crossref
Christian Mathy, Ken Schneider, Yunn-Yi Chen, Madhulika Varma, Jonathan P. Terdiman & Uma Mahadevan. (2003) Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis. Inflammatory Bowel Diseases 9:6, pages 351-355.
Crossref
Crossref
Geert D'Haens & Paul Rutgeerts. 2003. Colonoscopy. Colonoscopy
573
581
.
M. Campieri, S. Adamo, D. Valpiani, A. D'Arienzo, G. D'Albasio, M. Pitzalis, P. Cesari, T. Casetti, G. N. Castiglione, F. Rizzello, F. Manguso, G. Varoli & P. Gionchetti. (2003) Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. Alimentary Pharmacology & Therapeutics 17:12, pages 1471-1480.
Crossref
Crossref
Remo Panaccione & Lloyd R. Sutherland. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
269
290
.
Khoon-Lin Ling, Choon-Jin Ooi, Widjaja Luman, Wei-Kuen Cheong, Francis Seow Choen & Han-Seong Ng. (2002) Clinical Characteristics of Ulcerative Colitis in Singapore, a Multiracial City–State. Journal of Clinical Gastroenterology 35:2, pages 144-148.
Crossref
Crossref
G BOUMA, J B A CRUSIUS, M A GARCÍA-GONZÁLEZ, B U G A MEIJER, H P R HELLEMANS, R J HAKVOORT, G M Th. SCHREUDER, P J KOSTENSE, S G M MEUWISSEN & A S PEÑA. (1999) Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clinical and Experimental Immunology 115:2, pages 294-300.
Crossref
Crossref
Alain Bitton, Gary Wild, Michael D. DeB Edwardes, Mark A. Peppercorn & A.C. Stevens. (2001) Reply. Gastroenterology 121:5, pages 1262.
Crossref
Crossref
Chinyu Su, Gary R Lichtenstein & Gary R. Lichtenstein. (2000) Diagnosis of Crohn's Disease: A Wolf in Sheep's Clothing?. American Journal of Gastroenterology 95:12, pages 3345-3350.
Crossref
Crossref
Matthew Miller & Alastair Windsor. (2000) Ulcerative colitis. Hospital Medicine 61:10, pages 698-702.
Crossref
Crossref
Bjørn Moum. (2000) Medical treatment: does it influence the natural course of inflammatory bowel disease?. European Journal of Internal Medicine 11:4, pages 197-203.
Crossref
Crossref
John K Marshall & Jan E Irvine. (2000) Putting Rectal 5-Aminosalicylic Acid in Its Place: The Role in Distal Ulcerative Colitis. American Journal of Gastroenterology 95:7, pages 1628-1636.
Crossref
Crossref
Cornelia M. Gelbmann. (2000) Prediction of Treatment Refractoriness in Ulcerative Colitis and Crohnʼs Disease—Do We Have Reliable Markers?. Inflammatory Bowel Diseases 6:2, pages 123-131.
Crossref
Crossref
Gianmichele Meucci, Maurizio Vecchi, Marco Astegiano, Luigi Beretta, Pietro Cesari, Paolo Dizioli, Luca Ferraris, Maria Rita Panelli, Alberto Prada, Raffaello Sostegni & Roberto de Franchis. (2000) The Natural History of Ulcerative Proctitis: A Multicenter, Retrospective Study. American Journal of Gastroenterology 95:2, pages 469-473.
Crossref
Crossref
J. Schölmerich. 2000. Trends in Inflammatory Bowel Disease Therapy 1999. Trends in Inflammatory Bowel Disease Therapy 1999
117
127
.
S. B. Hanauer. 2000. Trends in Inflammatory Bowel Disease Therapy 1999. Trends in Inflammatory Bowel Disease Therapy 1999
107
116
.
Pietro G. Andres & Lawrence S. Friedman. (1999) EPIDEMIOLOGY AND THE NATURAL COURSE OF INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 28:2, pages 255-281.
Crossref
Crossref
Maureen O'Reilly Brown. (1999) INFLAMMATORY BOWEL DISEASE. Primary Care: Clinics in Office Practice 26:1, pages 141-170.
Crossref
Crossref
John K. Triantafillidis, Anastasios Emmanouilidis, Orestis N. Manousos, Efstathios Pomonis, Chrisa Tsitsa, Petros Cheracakis & Charalambos Barbatzas. (1998) Ulcerative Colitis in Greece: Clinicoepidemiological Data, Course, and Prognostic Factors in 413 Consecutive Patients. Journal of Clinical Gastroenterology 27:3, pages 204-210.
Crossref
Crossref
L. R. Sutherland, S. Hanauer & J. Scholmerich. (1997) Standards for Trials of Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 3:4, pages 277-283.
Crossref
Crossref